{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:33:13Z","timestamp":1791253993964,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,20]]},"DOI":"10.7759\/cureus.35216","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T14:35:13Z","timestamp":1676903713000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinical Conundrum of Acute Hepatitis B With Concurrent Hepatitis E Infection Leading to Severe Acute Liver Injury"],"prefix":"10.7759","author":[{"given":"Faryal","family":"Altaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaheer A","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Kandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misbahuddin","family":"Khaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12081","article-title":"Management of acute hepatitis B and reactivation of hepatitis B","volume":"33","author":"Jindal A","year":"2013","unstructured":"Jindal A, Kumar M, Sarin SK. Management of acute hepatitis B and reactivation of hepatitis B. Liver Int. 2013, 33:164-75. 10.1111\/liv.12081","journal-title":"Liver Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1208937","article-title":"Acute liver failure","volume":"369","author":"Bernal W","year":"2013","unstructured":"Bernal W, Wendon J. Acute liver failure. N Engl J Med. 2013, 369:2525-34. 10.1056\/NEJMra1208937","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2011.0714","article-title":"Acute liver failure: a life-threatening disease","volume":"108","author":"Canbay A","year":"2011","unstructured":"Canbay A, Tacke F, Hadem J, Trautwein C, Gerken G, Manns MP. Acute liver failure: a life-threatening disease. Dtsch Arztebl Int. 2011, 108:714-20. 10.3238\/arztebl.2011.0714","journal-title":"Dtsch Arztebl Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000444915","article-title":"Liver failure due to acute viral hepatitis (A-E)","volume":"32","author":"Manka P","year":"2016","unstructured":"Manka P, Verheyen J, Gerken G, Canbay A. Liver failure due to acute viral hepatitis (A-E). Visc Med. 2016, 32:80-5. 10.1159\/000444915","journal-title":"Visc Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"Lavanchy D","year":"2004","unstructured":"Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004, 11:97-107. 10.1046\/j.1365-2893.2003.00487.x","journal-title":"J Viral Hepat"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i35.5904","article-title":"Influence of chronic HBV infection on superimposed acute hepatitis E","volume":"19","author":"Cheng SH","year":"2013","unstructured":"Cheng SH, Mai L, Zhu FQ, et al.. Influence of chronic HBV infection on superimposed acute hepatitis E. World J Gastroenterol. 2013, 19:5904-9. 10.3748\/wjg.v19.i35.5904","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0801644","article-title":"Hepatitis B virus infection","volume":"359","author":"Dienstag JL","year":"2008","unstructured":"Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008, 359:1486-500. 10.1056\/NEJMra0801644","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"6","author":"Tr\u00e9po C","year":"2014","unstructured":"Tr\u00e9po C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014, 6:2053-63. 10.1016\/S0140-6736(14)60220-8","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault NA","year":"2018","unstructured":"Terrault NA, Lok AS, McMahon BJ, et al.. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018, 67:1560-99. 10.1002\/hep.29800","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312163292508","article-title":"Acute liver failure","volume":"329","author":"Lee WM","year":"1993","unstructured":"Lee WM. Acute liver failure. N Engl J Med. 1993, 329:1862-72. 10.1056\/NEJM199312163292508","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50113","article-title":"Thrombopoietin in acute liver failure","volume":"37","author":"Schi\u00f8dt FV","year":"2003","unstructured":"Schi\u00f8dt FV, Balko J, Schilsky M, Harrison ME, Thornton A, Lee WM. Thrombopoietin in acute liver failure. Hepatology. 2003, 37:558-61. 10.1053\/jhep.2003.50113","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22177","article-title":"Acute liver failure: summary of a workshop","volume":"47","author":"Lee WM","year":"2008","unstructured":"Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008, 47:1401-15. 10.1002\/hep.22177","journal-title":"Hepatology"},{"key":"ref13","article-title":"NIH consensus development statement on management of hepatitis B","volume":"25","author":"Belongia EA","year":"2008","unstructured":"Belongia EA, Costa J, Gareen IF, et al.. NIH consensus development statement on management of hepatitis B. NIH Consens State Sci Statements. 2008, 25:1-29.","journal-title":"NIH Consens State Sci Statements"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02682.x","article-title":"Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?","volume":"32","author":"Tillmann HL","year":"2012","unstructured":"Tillmann HL, Zachou K, Dalekos GN. Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?. Liver Int. 2012, 32:544-53. 10.1111\/j.1478-3231.2011.02682.x","journal-title":"Liver Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/v2061279","article-title":"Antiviral treatment of chronic hepatitis B virus (HBV) infections","volume":"2","author":"De Clercq E","year":"2010","unstructured":"De Clercq E, F\u00e9rir G, Kaptein S, Neyts J. Antiviral treatment of chronic hepatitis B virus (HBV) infections. Viruses. 2010, 2:1279-305. 10.3390\/v2061279","journal-title":"Viruses"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24109","article-title":"Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure","volume":"53","author":"Garg H","year":"2011","unstructured":"Garg H, Sarin SK, Kumar M, Garg V, Sharma BC, Kumar A. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology. 2011, 53:774-80. 10.1002\/hep.24109","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.7.2720-2728.2005","article-title":"Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection","volume":"49","author":"Menne S","year":"2005","unstructured":"Menne S, Cote PJ, Korba BE, et al.. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection. Antimicrob Agents Chemother. 2005, 49:2720-8. 10.1128\/AAC.49.7.2720-2728.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)90081-4","article-title":"Early indicators of prognosis in fulminant hepatic failure","volume":"97","author":"O'Grady JG","year":"1989","unstructured":"O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989, 97:439-45. 10.1016\/0016-5085(89)90081-4","journal-title":"Gastroenterology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21104","article-title":"MELD is superior to King's College and Clichy's criteria to assess prognosis in fulminant hepatic failure","volume":"13","author":"Yantorno SE","year":"2007","unstructured":"Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podest\u00e1 LG, Villamil FG. MELD is superior to King's College and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl. 2007, 13:822-8. 10.1002\/lt.21104","journal-title":"Liver Transpl"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7326\/M15-2211","article-title":"Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study","volume":"164","author":"Reuben A","year":"2016","unstructured":"Reuben A, Tillman H, Fontana RJ, et al.. Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study. Ann Intern Med. 2016, 164:724-32. 10.7326\/M15-2211","journal-title":"Ann Intern Med"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1016\/S0889-8553(21)00066-2","article-title":"Liver transplantation for fulminant hepatic failure","volume":"22","author":"Lidofsky SD","year":"1993","unstructured":"Lidofsky SD. Liver transplantation for fulminant hepatic failure. Gastroenterol Clin North Am. 1993, 22:257-69.","journal-title":"Gastroenterol Clin North Am"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/030089160609200417","article-title":"Acute liver failure as the initial manifestation of hepatic infiltration by a solid tumor: report of 5 cases and review of the literature","volume":"92","author":"Alexopoulou A","year":"2006","unstructured":"Alexopoulou A, Koskinas J, Deutsch M, Delladetsima J, Kountouras D, Dourakis SP. Acute liver failure as the initial manifestation of hepatic infiltration by a solid tumor: report of 5 cases and review of the literature. Tumori. 2006, 92:354-7. 10.1177\/030089160609200417","journal-title":"Tumori"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.08.033","article-title":"Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management","volume":"61","author":"Chang ML","year":"2014","unstructured":"Chang ML, Liaw YF. Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management. J Hepatol. 2014, 61:1407-17. 10.1016\/j.jhep.2014.08.033","journal-title":"J Hepatol"},{"key":"ref24","article-title":"Lamivudine treatment for acute severe hepatitis B: report of a case and review of the literature","volume":"71","author":"Roussos A","year":"2008","unstructured":"Roussos A, Koilakou S, Kalafatas I, et al.. Lamivudine treatment for acute severe hepatitis B: report of a case and review of the literature. Acta Gastroenterol Belg. 2008, 71:30-2.","journal-title":"Acta Gastroenterol Belg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.47.1061","article-title":"Lamivudine treatment improves the prognosis of fulminant hepatitis B","volume":"47","author":"Miyake Y","year":"2008","unstructured":"Miyake Y, Iwasaki Y, Takaki A, et al.. Lamivudine treatment improves the prognosis of fulminant hepatitis B. Intern Med. 2008, 47:1293-9. 10.2169\/internalmedicine.47.1061","journal-title":"Intern Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-2013-3","article-title":"Use of nucleoside (tide) analogues in patients with hepatitis B-related acute liver failure","volume":"57","author":"Dao DY","year":"2012","unstructured":"Dao DY, Seremba E, Ajmera V, Sanders C, Hynan LS, Lee WM. Use of nucleoside (tide) analogues in patients with hepatitis B-related acute liver failure. Dig Dis Sci. 2012, 57:1349-57. 10.1007\/s10620-011-2013-3","journal-title":"Dig Dis Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/138176-clinical-conundrum-of-acute-hepatitis-b-with-concurrent-hepatitis-e-infection-leading-to-severe-acute-liver-injury","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:36Z","timestamp":1707508296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/138176-clinical-conundrum-of-acute-hepatitis-b-with-concurrent-hepatitis-e-infection-leading-to-severe-acute-liver-injury"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.35216","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,20]]}}}